Back to search

Article

Effect of Losartan on Symptomatic Outpatients with COVID-19: A Randomized Clinical Trial

2021-02-17

Abstract excerpt

Background: The SARS-CoV-2 virus enters cells via the ACE2 receptor, disrupting the renin-angiotensin-aldosterone axis, potentially contributing to lung injury. Treatment with angiotensin receptor blockers(ARBs) may mitigate these effects, though induction of ACE2 expression could increase viral entry, replication, and worsen disease.<br><br>Methods: This study represents a placebo-controlled blinded randomized cl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e8b622cf-18e4-5d83-b401-a222f99337f3
DOI
10.2139/ssrn.3787463
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effect of Losartan on Symptomatic Outpatients with COVID-19: A Randomized Clinical TrialDOI 10.2139/ssrn.3787463
Select a neighboring publication to make it the new centre.